Obatala Sciences: Obatala Sciences licenses technology from Harvard University to advance discovery in obesity, diabetes, and cancer

NEW ORLEANS and CAMBRIDGE, Mass., June 2, 2021 /PRNewswire/ - Obatala Sciences, a biotechnology company that manufactures stem cell and hydrogel products to enable next-generation therapeutics discovery, has been granted an exclusive license from Harvard University to commercialize innovations that enable the study of human fat tissue in vitro. Obatala and Harvard Office of Technology Development announced [...]The post Obatala Sciences licenses technology from Harvard University to advance discovery in obesity, diabetes, and cancer first appeared on Plato. Vertical Search. Ai..